Large Cell Carcinoma — Research

Large Cell Carcinoma — Research · CancerIndex

Research activity

PubMed record counts

Each count is the number of PubMed records returned by the exact query shown, at the time it was run. Counts are research-activity signals, not quality measures.

pubmedComputed3 windows · counts computed by CancerIndex from PubMed E-utilities; the exact query is stored with each count.

Window	Period	Records (count)	Exact query	Computed	Source
All time	… → 2026-09-11	2,694	`("Carcinoma, Large Cell"[mh] OR "Cell Carcinoma, Large"[mh])`	2026-09-11	pubmed
Last 5 years	2021-01-01 → 2026-12-31	223	`("Carcinoma, Large Cell"[mh] OR "Cell Carcinoma, Large"[mh]) AND (2021/01/01:2026/12/31[dp])`	2026-09-11	pubmed
Last 12 months	2025-09-11 → 2026-09-11	47	`("Carcinoma, Large Cell"[mh] OR "Cell Carcinoma, Large"[mh]) AND (2025/09/11:2026/09/11[dp])`	2026-09-11	pubmed

Data updated 19 days agoSource updated unknownsource: pubmed E-utilities

Literature

Linked publications (5)

Publications linked to this entity or its descendants, newest first, 25 per page. Link method and validation status are shown; 'candidate' links have not been reviewed.

pubmedPublishedShowing 1–5 of 5 publications · bibliographic data as recorded by PubMed; abstracts are not reproduced.

Vemurafenib in Multiple Nonmelanoma Cancers with BRAF V600 Mutations.Retracted
· N Engl J Med · 2015 · PMID 26287849 · validated civic_curation pubmed
Targeted Therapy for Advanced Solid Tumors on the Basis of Molecular Profiles: Results From MyPathway, an Open-Label, Phase IIa Multiple Basket Study.
· J Clin Oncol · 2018 · PMID 29320312 · validated civic_curation pubmed
Dabrafenib and Trametinib Treatment in Patients With Locally Advanced or Metastatic BRAF V600-Mutant Anaplastic Thyroid Cancer.
· J Clin Oncol · 2018 · PMID 29072975 · validated civic_curation pubmed
Response and acquired resistance to everolimus in anaplastic thyroid cancer.